Share Price and Basic Stock Data
Last Updated: January 24, 2026, 4:03 pm
| PEG Ratio | 0.47 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Himadri Speciality Chemical Ltd operates in the specialty chemicals sector, focusing on various chemical products. The company reported a market capitalization of ₹22,812 Cr, with its stock price standing at ₹453. Over the last fiscal year, Himadri has demonstrated robust revenue growth, with sales increasing from ₹2,791 Cr in March 2022 to ₹4,172 Cr in March 2023. This upward trajectory continued into the current fiscal year, with trailing twelve months (TTM) sales reaching ₹4,465 Cr. Quarterly sales data reveals a consistent performance, with revenues of ₹1,059 Cr in September 2022, peaking at ₹1,177 Cr in March 2024. The company’s operational efficiency is reflected in its operating profit margin (OPM), which rose from 9% in September 2022 to 22% in June 2025. Despite a decline in sales to ₹951 Cr in June 2023, the overall trend indicates strong resilience and capacity for recovery, as evidenced by subsequent quarterly improvements.
Profitability and Efficiency Metrics
Himadri’s profitability metrics paint a positive picture, with net profit standing at ₹652 Cr for the latest fiscal year. The company has reported a significant rise in earnings per share (EPS), which increased from ₹0.86 in September 2022 to ₹11.26 in March 2025. This growth in profitability is supported by an impressive return on equity (ROE) of 16.4% and return on capital employed (ROCE) of 22%, which are favorable compared to industry averages. The interest coverage ratio (ICR) is notably high at 20.23x, indicating strong capability to meet interest obligations. The company’s operational efficiency is further substantiated by a cash conversion cycle (CCC) of 90 days, reflecting effective management of receivables and inventory. Additionally, the operating profit margin (OPM) has shown a consistent improvement, indicating enhanced operational efficiency and cost control measures.
Balance Sheet Strength and Financial Ratios
The balance sheet of Himadri Speciality Chemical Ltd indicates a solid financial foundation with total assets amounting to ₹5,518 Cr as of September 2025. The company’s reserves have substantially increased, reaching ₹4,020 Cr, which provides a cushion for future growth initiatives. Borrowings stood at ₹864 Cr, maintaining a low total debt-to-equity ratio of 0.08, illustrating prudent financial management and low leverage. The current ratio is robust at 3.56, suggesting ample liquidity to cover short-term obligations. However, the price-to-book value (P/BV) ratio of 5.62x indicates that the stock may be trading at a premium relative to its book value. This could suggest market expectations for continued growth. The enterprise value (EV) of ₹20,620 Cr, combined with a low EV/EBITDA of 22.76, further highlights the company’s valuation dynamics in the specialty chemicals space.
Shareholding Pattern and Investor Confidence
The shareholding structure of Himadri Speciality Chemical Ltd reflects a balanced distribution of ownership, with promoters holding 52.50% as of November 2025. This significant promoter stake is complemented by foreign institutional investors (FIIs) at 5.62% and domestic institutional investors (DIIs) at 3.18%, indicating a moderate level of institutional interest. The public shareholding constitutes 38.69%, with a growing number of shareholders reaching 4,44,893. The gradual increase in promoter ownership from 45.61% in March 2023 to 52.50% in November 2025 suggests rising confidence in the company’s future prospects. Furthermore, the increase in FII participation from 2.36% to 5.62% over the same period signifies enhanced foreign interest. This evolving shareholding pattern indicates positive sentiment among investors, reinforcing confidence in the company’s strategic direction and operational performance.
Outlook, Risks, and Final Insight
Looking ahead, Himadri Speciality Chemical Ltd appears well-positioned for continued growth, bolstered by strong revenue trends and profitability metrics. However, potential risks include fluctuating raw material prices that could impact margins and the competitive landscape within the specialty chemicals sector, which may pressure pricing strategies. Additionally, the company’s reliance on a relatively low level of borrowings could be tested by economic fluctuations or changes in interest rates. While the financial indicators suggest a robust outlook, the company must navigate these challenges to sustain its growth trajectory. If it successfully implements its growth strategies while maintaining operational efficiency, Himadri could further enhance its market position. Conversely, failure to manage external pressures could hinder performance, necessitating a careful approach to risk management and strategic planning.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| HP Adhesives Ltd | 345 Cr. | 37.5 | 71.7/36.8 | 21.4 | 20.5 | 1.07 % | 13.6 % | 9.82 % | 2.00 |
| Haryana Leather Chemicals Ltd | 28.0 Cr. | 57.0 | 88.8/55.0 | 13.4 | 89.6 | 1.75 % | 8.02 % | 5.45 % | 10.0 |
| Hardcastle & Waud Mfg Co Ltd | 44.5 Cr. | 655 | 899/600 | 20.5 | 697 | 0.00 % | 6.31 % | 2.91 % | 10.0 |
| Grauer & Weil (India) Ltd | 3,221 Cr. | 71.0 | 111/68.2 | 21.3 | 22.0 | 0.70 % | 23.3 % | 17.6 % | 1.00 |
| DMCC Speciality Chemicals Ltd | 547 Cr. | 219 | 377/213 | 19.6 | 93.8 | 1.14 % | 14.1 % | 9.97 % | 10.0 |
| Industry Average | 12,127.48 Cr | 644.51 | 58.17 | 182.97 | 0.47% | 12.99% | 25.41% | 6.41 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,059 | 1,037 | 1,029 | 951 | 1,005 | 1,053 | 1,177 | 1,200 | 1,137 | 1,141 | 1,135 | 1,118 | 1,071 |
| Expenses | 962 | 932 | 903 | 817 | 847 | 879 | 997 | 1,008 | 929 | 920 | 901 | 873 | 838 |
| Operating Profit | 97 | 105 | 126 | 134 | 158 | 174 | 180 | 192 | 208 | 221 | 233 | 245 | 233 |
| OPM % | 9% | 10% | 12% | 14% | 16% | 17% | 15% | 16% | 18% | 19% | 21% | 22% | 22% |
| Other Income | -22 | 8 | 11 | 10 | 10 | 10 | 12 | 13 | 14 | 12 | 14 | 27 | 36 |
| Interest | 20 | 20 | 13 | 13 | 16 | 21 | 14 | 13 | 11 | 12 | 9 | 16 | 15 |
| Depreciation | 13 | 13 | 12 | 12 | 12 | 13 | 13 | 13 | 13 | 15 | 14 | 15 | 17 |
| Profit before tax | 42 | 79 | 111 | 119 | 139 | 150 | 166 | 179 | 197 | 206 | 224 | 241 | 237 |
| Tax % | 15% | 18% | 31% | 28% | 28% | 28% | 30% | 31% | 31% | 31% | 31% | 26% | 26% |
| Net Profit | 36 | 65 | 76 | 86 | 101 | 109 | 115 | 123 | 136 | 141 | 155 | 179 | 176 |
| EPS in Rs | 0.86 | 1.55 | 1.76 | 1.96 | 2.29 | 2.47 | 2.34 | 2.48 | 2.74 | 2.88 | 3.15 | 3.68 | 3.57 |
Last Updated: January 1, 2026, 11:16 am
Below is a detailed analysis of the quarterly data for Himadri Speciality Chemical Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 1,071.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,118.00 Cr. (Jun 2025) to 1,071.00 Cr., marking a decrease of 47.00 Cr..
- For Expenses, as of Sep 2025, the value is 838.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 873.00 Cr. (Jun 2025) to 838.00 Cr., marking a decrease of 35.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 233.00 Cr.. The value appears to be declining and may need further review. It has decreased from 245.00 Cr. (Jun 2025) to 233.00 Cr., marking a decrease of 12.00 Cr..
- For OPM %, as of Sep 2025, the value is 22.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 22.00%.
- For Other Income, as of Sep 2025, the value is 36.00 Cr.. The value appears strong and on an upward trend. It has increased from 27.00 Cr. (Jun 2025) to 36.00 Cr., marking an increase of 9.00 Cr..
- For Interest, as of Sep 2025, the value is 15.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 16.00 Cr. (Jun 2025) to 15.00 Cr., marking a decrease of 1.00 Cr..
- For Depreciation, as of Sep 2025, the value is 17.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 15.00 Cr. (Jun 2025) to 17.00 Cr., marking an increase of 2.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 237.00 Cr.. The value appears to be declining and may need further review. It has decreased from 241.00 Cr. (Jun 2025) to 237.00 Cr., marking a decrease of 4.00 Cr..
- For Tax %, as of Sep 2025, the value is 26.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 26.00%.
- For Net Profit, as of Sep 2025, the value is 176.00 Cr.. The value appears to be declining and may need further review. It has decreased from 179.00 Cr. (Jun 2025) to 176.00 Cr., marking a decrease of 3.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 3.57. The value appears to be declining and may need further review. It has decreased from 3.68 (Jun 2025) to 3.57, marking a decrease of 0.11.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:15 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,395 | 1,437 | 1,182 | 1,341 | 2,022 | 2,422 | 1,806 | 1,679 | 2,791 | 4,172 | 4,185 | 4,613 | 4,465 |
| Expenses | 1,307 | 1,313 | 1,036 | 1,107 | 1,569 | 1,863 | 1,525 | 1,549 | 2,635 | 3,773 | 3,540 | 3,758 | 3,533 |
| Operating Profit | 88 | 124 | 146 | 233 | 452 | 560 | 280 | 131 | 156 | 399 | 645 | 854 | 932 |
| OPM % | 6% | 9% | 12% | 17% | 22% | 23% | 16% | 8% | 6% | 10% | 15% | 19% | 21% |
| Other Income | 13 | 13 | 9 | 6 | 12 | 8 | 8 | 14 | -17 | -2 | 43 | 52 | 88 |
| Interest | 118 | 103 | 111 | 82 | 70 | 71 | 55 | 33 | 36 | 66 | 64 | 45 | 51 |
| Depreciation | 58 | 59 | 67 | 33 | 33 | 34 | 39 | 47 | 50 | 51 | 50 | 55 | 61 |
| Profit before tax | -75 | -24 | -23 | 125 | 361 | 462 | 194 | 65 | 53 | 280 | 574 | 806 | 908 |
| Tax % | -22% | -49% | -19% | 34% | 31% | 30% | -6% | 27% | 27% | 23% | 28% | 31% | |
| Net Profit | -58 | -13 | -19 | 82 | 248 | 324 | 205 | 47 | 39 | 216 | 411 | 555 | 652 |
| EPS in Rs | -1.48 | -0.32 | -0.44 | 1.98 | 5.91 | 7.75 | 4.91 | 1.13 | 0.98 | 4.99 | 8.34 | 11.25 | 13.28 |
| Dividend Payout % | -7% | 0% | -11% | 5% | 2% | 2% | 3% | 13% | 20% | 5% | 6% | 5% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 77.59% | -46.15% | 531.58% | 202.44% | 30.65% | -36.73% | -77.07% | -17.02% | 453.85% | 90.28% | 35.04% |
| Change in YoY Net Profit Growth (%) | 0.00% | -123.74% | 577.73% | -329.14% | -171.79% | -67.37% | -40.34% | 60.05% | 470.87% | -363.57% | -55.24% |
Himadri Speciality Chemical Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 21% |
| 3 Years: | 18% |
| TTM: | 2% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 40% |
| 5 Years: | 22% |
| 3 Years: | 111% |
| TTM: | 37% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 41% |
| 5 Years: | 53% |
| 3 Years: | 65% |
| 1 Year: | -15% |
| Return on Equity | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 11% |
| 3 Years: | 15% |
| Last Year: | 16% |
Last Updated: September 5, 2025, 6:10 am
Balance Sheet
Last Updated: December 10, 2025, 2:47 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 39 | 39 | 42 | 42 | 42 | 42 | 42 | 42 | 42 | 43 | 49 | 49 | 49 |
| Reserves | 757 | 750 | 837 | 988 | 1,373 | 1,590 | 1,692 | 1,751 | 1,826 | 2,237 | 2,996 | 3,672 | 4,020 |
| Borrowings | 1,362 | 1,124 | 887 | 774 | 660 | 476 | 505 | 729 | 587 | 842 | 605 | 313 | 864 |
| Other Liabilities | 339 | 329 | 296 | 308 | 341 | 680 | 323 | 269 | 999 | 555 | 798 | 621 | 585 |
| Total Liabilities | 2,497 | 2,242 | 2,062 | 2,112 | 2,416 | 2,788 | 2,562 | 2,791 | 3,454 | 3,678 | 4,449 | 4,656 | 5,518 |
| Fixed Assets | 1,221 | 1,228 | 1,180 | 1,174 | 1,178 | 1,170 | 1,475 | 1,468 | 1,546 | 1,515 | 1,534 | 1,605 | 1,663 |
| CWIP | 59 | 14 | 31 | 13 | 22 | 133 | 158 | 160 | 77 | 94 | 67 | 185 | 443 |
| Investments | 168 | 23 | 53 | 87 | 273 | 179 | 47 | 66 | 113 | 132 | 478 | 582 | 723 |
| Other Assets | 1,048 | 977 | 798 | 838 | 943 | 1,305 | 882 | 1,098 | 1,718 | 1,938 | 2,371 | 2,283 | 2,688 |
| Total Assets | 2,497 | 2,242 | 2,062 | 2,112 | 2,416 | 2,788 | 2,562 | 2,791 | 3,454 | 3,678 | 4,449 | 4,656 | 5,518 |
Below is a detailed analysis of the balance sheet data for Himadri Speciality Chemical Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 49.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 49.00 Cr..
- For Reserves, as of Sep 2025, the value is 4,020.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,672.00 Cr. (Mar 2025) to 4,020.00 Cr., marking an increase of 348.00 Cr..
- For Borrowings, as of Sep 2025, the value is 864.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 313.00 Cr. (Mar 2025) to 864.00 Cr., marking an increase of 551.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 585.00 Cr.. The value appears to be improving (decreasing). It has decreased from 621.00 Cr. (Mar 2025) to 585.00 Cr., marking a decrease of 36.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 5,518.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4,656.00 Cr. (Mar 2025) to 5,518.00 Cr., marking an increase of 862.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,663.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,605.00 Cr. (Mar 2025) to 1,663.00 Cr., marking an increase of 58.00 Cr..
- For CWIP, as of Sep 2025, the value is 443.00 Cr.. The value appears strong and on an upward trend. It has increased from 185.00 Cr. (Mar 2025) to 443.00 Cr., marking an increase of 258.00 Cr..
- For Investments, as of Sep 2025, the value is 723.00 Cr.. The value appears strong and on an upward trend. It has increased from 582.00 Cr. (Mar 2025) to 723.00 Cr., marking an increase of 141.00 Cr..
- For Other Assets, as of Sep 2025, the value is 2,688.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,283.00 Cr. (Mar 2025) to 2,688.00 Cr., marking an increase of 405.00 Cr..
- For Total Assets, as of Sep 2025, the value is 5,518.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,656.00 Cr. (Mar 2025) to 5,518.00 Cr., marking an increase of 862.00 Cr..
Notably, the Reserves (4,020.00 Cr.) exceed the Borrowings (864.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 87.00 | 123.00 | -741.00 | -541.00 | -208.00 | 84.00 | -225.00 | -598.00 | -431.00 | -443.00 | 40.00 | 541.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 92 | 82 | 63 | 60 | 49 | 55 | 61 | 100 | 66 | 44 | 57 | 50 |
| Inventory Days | 134 | 122 | 138 | 164 | 112 | 124 | 121 | 100 | 125 | 61 | 85 | 68 |
| Days Payable | 36 | 36 | 50 | 74 | 39 | 100 | 68 | 45 | 127 | 39 | 69 | 28 |
| Cash Conversion Cycle | 191 | 168 | 151 | 150 | 122 | 79 | 113 | 155 | 65 | 66 | 73 | 90 |
| Working Capital Days | -11 | 4 | -22 | 19 | 29 | 40 | 10 | 15 | -1 | 1 | 32 | 69 |
| ROCE % | 2% | 3% | 5% | 11% | 22% | 25% | 11% | 4% | 5% | 13% | 19% | 22% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Quant ELSS Tax Saver Fund | 2,362,973 | 0.83 | 103.4 | N/A | N/A | N/A |
| Quant Small Cap Fund | 674,478 | 0.1 | 29.52 | N/A | N/A | N/A |
| Bandhan Infrastructure Fund | 106,723 | 0.3 | 4.67 | 234,368 | 2025-12-14 08:52:11 | -54.46% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 11.26 | 9.16 | 5.13 | 0.98 | 1.13 |
| Diluted EPS (Rs.) | 11.17 | 9.16 | 5.13 | 0.98 | 1.13 |
| Cash EPS (Rs.) | 12.35 | 9.35 | 6.16 | 2.11 | 2.25 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 75.37 | 61.77 | 52.64 | 44.51 | 42.78 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 75.37 | 61.77 | 52.64 | 44.51 | 42.78 |
| Revenue From Operations / Share (Rs.) | 93.41 | 84.96 | 96.41 | 66.62 | 40.09 |
| PBDIT / Share (Rs.) | 18.35 | 13.96 | 9.87 | 3.90 | 3.46 |
| PBIT / Share (Rs.) | 17.23 | 12.95 | 8.70 | 2.71 | 2.34 |
| PBT / Share (Rs.) | 16.33 | 11.65 | 6.48 | 1.28 | 1.54 |
| Net Profit / Share (Rs.) | 11.24 | 8.34 | 4.99 | 0.93 | 1.13 |
| NP After MI And SOA / Share (Rs.) | 11.25 | 8.34 | 4.99 | 0.97 | 1.13 |
| PBDIT Margin (%) | 19.63 | 16.43 | 10.23 | 5.84 | 8.63 |
| PBIT Margin (%) | 18.44 | 15.23 | 9.02 | 4.07 | 5.83 |
| PBT Margin (%) | 17.47 | 13.71 | 6.71 | 1.91 | 3.84 |
| Net Profit Margin (%) | 12.03 | 9.81 | 5.17 | 1.39 | 2.81 |
| NP After MI And SOA Margin (%) | 12.04 | 9.81 | 5.17 | 1.46 | 2.82 |
| Return on Networth / Equity (%) | 14.92 | 13.48 | 9.47 | 2.19 | 2.64 |
| Return on Capital Employeed (%) | 21.00 | 19.64 | 15.48 | 5.57 | 5.02 |
| Return On Assets (%) | 11.93 | 9.23 | 5.87 | 1.18 | 1.70 |
| Long Term Debt / Equity (X) | 0.00 | 0.01 | 0.02 | 0.04 | 0.04 |
| Total Debt / Equity (X) | 0.08 | 0.19 | 0.36 | 0.30 | 0.37 |
| Asset Turnover Ratio (%) | 1.01 | 1.03 | 1.17 | 0.90 | 0.63 |
| Current Ratio (X) | 3.56 | 1.92 | 1.51 | 1.18 | 1.25 |
| Quick Ratio (X) | 2.59 | 1.33 | 1.07 | 0.63 | 0.84 |
| Inventory Turnover Ratio (X) | 7.16 | 4.92 | 4.99 | 4.30 | 3.13 |
| Dividend Payout Ratio (NP) (%) | 4.44 | 2.63 | 3.88 | 15.34 | 13.23 |
| Dividend Payout Ratio (CP) (%) | 4.04 | 2.34 | 3.14 | 6.94 | 6.65 |
| Earning Retention Ratio (%) | 95.56 | 97.37 | 96.12 | 84.66 | 86.77 |
| Cash Earning Retention Ratio (%) | 95.96 | 97.66 | 96.86 | 93.06 | 93.35 |
| Interest Coverage Ratio (X) | 20.23 | 10.77 | 6.47 | 4.58 | 4.34 |
| Interest Coverage Ratio (Post Tax) (X) | 13.40 | 7.43 | 4.72 | 2.79 | 2.41 |
| Enterprise Value (Cr.) | 20619.97 | 14725.34 | 3988.71 | 3425.68 | 2287.01 |
| EV / Net Operating Revenue (X) | 4.47 | 3.52 | 0.95 | 1.23 | 1.36 |
| EV / EBITDA (X) | 22.76 | 21.42 | 9.34 | 20.98 | 15.78 |
| MarketCap / Net Operating Revenue (X) | 4.54 | 3.55 | 0.90 | 1.12 | 1.04 |
| Retention Ratios (%) | 95.55 | 97.36 | 96.11 | 84.65 | 86.76 |
| Price / BV (X) | 5.62 | 4.88 | 1.66 | 1.67 | 0.97 |
| Price / Net Operating Revenue (X) | 4.54 | 3.55 | 0.90 | 1.12 | 1.04 |
| EarningsYield | 0.02 | 0.02 | 0.05 | 0.01 | 0.02 |
After reviewing the key financial ratios for Himadri Speciality Chemical Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 11.26. This value is within the healthy range. It has increased from 9.16 (Mar 24) to 11.26, marking an increase of 2.10.
- For Diluted EPS (Rs.), as of Mar 25, the value is 11.17. This value is within the healthy range. It has increased from 9.16 (Mar 24) to 11.17, marking an increase of 2.01.
- For Cash EPS (Rs.), as of Mar 25, the value is 12.35. This value is within the healthy range. It has increased from 9.35 (Mar 24) to 12.35, marking an increase of 3.00.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 75.37. It has increased from 61.77 (Mar 24) to 75.37, marking an increase of 13.60.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 75.37. It has increased from 61.77 (Mar 24) to 75.37, marking an increase of 13.60.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 93.41. It has increased from 84.96 (Mar 24) to 93.41, marking an increase of 8.45.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 18.35. This value is within the healthy range. It has increased from 13.96 (Mar 24) to 18.35, marking an increase of 4.39.
- For PBIT / Share (Rs.), as of Mar 25, the value is 17.23. This value is within the healthy range. It has increased from 12.95 (Mar 24) to 17.23, marking an increase of 4.28.
- For PBT / Share (Rs.), as of Mar 25, the value is 16.33. This value is within the healthy range. It has increased from 11.65 (Mar 24) to 16.33, marking an increase of 4.68.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 11.24. This value is within the healthy range. It has increased from 8.34 (Mar 24) to 11.24, marking an increase of 2.90.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 11.25. This value is within the healthy range. It has increased from 8.34 (Mar 24) to 11.25, marking an increase of 2.91.
- For PBDIT Margin (%), as of Mar 25, the value is 19.63. This value is within the healthy range. It has increased from 16.43 (Mar 24) to 19.63, marking an increase of 3.20.
- For PBIT Margin (%), as of Mar 25, the value is 18.44. This value is within the healthy range. It has increased from 15.23 (Mar 24) to 18.44, marking an increase of 3.21.
- For PBT Margin (%), as of Mar 25, the value is 17.47. This value is within the healthy range. It has increased from 13.71 (Mar 24) to 17.47, marking an increase of 3.76.
- For Net Profit Margin (%), as of Mar 25, the value is 12.03. This value exceeds the healthy maximum of 10. It has increased from 9.81 (Mar 24) to 12.03, marking an increase of 2.22.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 12.04. This value is within the healthy range. It has increased from 9.81 (Mar 24) to 12.04, marking an increase of 2.23.
- For Return on Networth / Equity (%), as of Mar 25, the value is 14.92. This value is below the healthy minimum of 15. It has increased from 13.48 (Mar 24) to 14.92, marking an increase of 1.44.
- For Return on Capital Employeed (%), as of Mar 25, the value is 21.00. This value is within the healthy range. It has increased from 19.64 (Mar 24) to 21.00, marking an increase of 1.36.
- For Return On Assets (%), as of Mar 25, the value is 11.93. This value is within the healthy range. It has increased from 9.23 (Mar 24) to 11.93, marking an increase of 2.70.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.08. This value is within the healthy range. It has decreased from 0.19 (Mar 24) to 0.08, marking a decrease of 0.11.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.01. It has decreased from 1.03 (Mar 24) to 1.01, marking a decrease of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 3.56. This value exceeds the healthy maximum of 3. It has increased from 1.92 (Mar 24) to 3.56, marking an increase of 1.64.
- For Quick Ratio (X), as of Mar 25, the value is 2.59. This value exceeds the healthy maximum of 2. It has increased from 1.33 (Mar 24) to 2.59, marking an increase of 1.26.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.16. This value is within the healthy range. It has increased from 4.92 (Mar 24) to 7.16, marking an increase of 2.24.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 4.44. This value is below the healthy minimum of 20. It has increased from 2.63 (Mar 24) to 4.44, marking an increase of 1.81.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 4.04. This value is below the healthy minimum of 20. It has increased from 2.34 (Mar 24) to 4.04, marking an increase of 1.70.
- For Earning Retention Ratio (%), as of Mar 25, the value is 95.56. This value exceeds the healthy maximum of 70. It has decreased from 97.37 (Mar 24) to 95.56, marking a decrease of 1.81.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 95.96. This value exceeds the healthy maximum of 70. It has decreased from 97.66 (Mar 24) to 95.96, marking a decrease of 1.70.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 20.23. This value is within the healthy range. It has increased from 10.77 (Mar 24) to 20.23, marking an increase of 9.46.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 13.40. This value is within the healthy range. It has increased from 7.43 (Mar 24) to 13.40, marking an increase of 5.97.
- For Enterprise Value (Cr.), as of Mar 25, the value is 20,619.97. It has increased from 14,725.34 (Mar 24) to 20,619.97, marking an increase of 5,894.63.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.47. This value exceeds the healthy maximum of 3. It has increased from 3.52 (Mar 24) to 4.47, marking an increase of 0.95.
- For EV / EBITDA (X), as of Mar 25, the value is 22.76. This value exceeds the healthy maximum of 15. It has increased from 21.42 (Mar 24) to 22.76, marking an increase of 1.34.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 4.54. This value exceeds the healthy maximum of 3. It has increased from 3.55 (Mar 24) to 4.54, marking an increase of 0.99.
- For Retention Ratios (%), as of Mar 25, the value is 95.55. This value exceeds the healthy maximum of 70. It has decreased from 97.36 (Mar 24) to 95.55, marking a decrease of 1.81.
- For Price / BV (X), as of Mar 25, the value is 5.62. This value exceeds the healthy maximum of 3. It has increased from 4.88 (Mar 24) to 5.62, marking an increase of 0.74.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 4.54. This value exceeds the healthy maximum of 3. It has increased from 3.55 (Mar 24) to 4.54, marking an increase of 0.99.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Himadri Speciality Chemical Ltd:
- Net Profit Margin: 12.03%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 21% (Industry Average ROCE: 12.99%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 14.92% (Industry Average ROE: 25.41%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 13.4
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.59
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 31.9 (Industry average Stock P/E: 58.17)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.08
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 12.03%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Carbon Black | Fortuna Tower, 23-A, Netaji Subhas Road, Kolkata West Bengal 700001 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Anurag Choudhary | Chairman & M.D & CEO |
| Mr. Shyam Sundar Choudhary | Executive Director |
| Mr. Amit Choudhary | Executive Director |
| Mr. Girish Paman Vanvari | Independent Director |
| Mr. Gopal Ajay Malpani | Independent Director |
| Ms. Rita Bhattacharya | Independent Director |
| Mr. Amitabh Srivastava | Independent Director |
FAQ
What is the intrinsic value of Himadri Speciality Chemical Ltd?
Himadri Speciality Chemical Ltd's intrinsic value (as of 25 January 2026) is ₹568.87 which is 27.26% higher the current market price of ₹447.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹22,542 Cr. market cap, FY2025-2026 high/low of ₹534/351, reserves of ₹4,020 Cr, and liabilities of ₹5,518 Cr.
What is the Market Cap of Himadri Speciality Chemical Ltd?
The Market Cap of Himadri Speciality Chemical Ltd is 22,542 Cr..
What is the current Stock Price of Himadri Speciality Chemical Ltd as on 25 January 2026?
The current stock price of Himadri Speciality Chemical Ltd as on 25 January 2026 is ₹447.
What is the High / Low of Himadri Speciality Chemical Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Himadri Speciality Chemical Ltd stocks is ₹534/351.
What is the Stock P/E of Himadri Speciality Chemical Ltd?
The Stock P/E of Himadri Speciality Chemical Ltd is 31.9.
What is the Book Value of Himadri Speciality Chemical Ltd?
The Book Value of Himadri Speciality Chemical Ltd is 80.6.
What is the Dividend Yield of Himadri Speciality Chemical Ltd?
The Dividend Yield of Himadri Speciality Chemical Ltd is 0.13 %.
What is the ROCE of Himadri Speciality Chemical Ltd?
The ROCE of Himadri Speciality Chemical Ltd is 22.0 %.
What is the ROE of Himadri Speciality Chemical Ltd?
The ROE of Himadri Speciality Chemical Ltd is 16.4 %.
What is the Face Value of Himadri Speciality Chemical Ltd?
The Face Value of Himadri Speciality Chemical Ltd is 1.00.